All In MedTech

Device Trial Radar · NCT03466918

China S3: Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 THV in the Chinese Population

Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 Transcatheter Heart Valve (THV) in the Chinese Population

Last checked: Nov 20, 2026Latest source record: Sep 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

58

Actual

Start

May 23, 2018

Primary completion

Jul 3, 2019

Study completion Jun 19, 2024

Sponsor

Lead sponsor
Edwards LifesciencesPublic (EW)
Sponsor type
Industry
First posted
Mar 15, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety and effectiveness of the SAPIEN 3 (Edwards Lifesciences, Irvine, California) transcatheter heart valve implantation (TAVI) in Chinese patients with symptomatic severe calcific aortic stenosis who are considered at high risk for surgical valve replacement.

Conditions

  • Aortic Stenosis
  • Symptomatic Aortic Stenosis
  • Aortic Regurgitation

Interventions

  • SAPIEN 3 THV with the Commander delivery systemDevice

    Edwards SAPIEN 3 Transcatheter Heart Valve is implanted using the Commander delivery system

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. All-cause MortalityTime frame: 30-days

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Fuwai Hospital, CAMS&PUMC

    Beijing, China

  • WestChina Hospital, Sichuan University

    Chengdu, China

  • The Second Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, China

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.